Importance of probiotics and prebiotics and their mechanism of immune action against COVID-19: a narrative review

Abstract

The study investigated the role of probiotics and prebiotics in treating COVID-19. It focuses on their mechanisms of action in modulating the immune system and mitigating the disease’s impact. The research focused on the significance of the gut-lung axis and the potential benefits of probiotics and prebiotics against COVID-19. The research identified several findings: probiotics have shown potential in reducing the severity of COVID-19 symptoms and improving patient outcomes. The gut microbiota plays a critical role in the body’s immune response to COVID-19, with probiotics aiding in restoring its balance. Both can modulate the immune system, reducing the inflammatory response associated with COVID-19. While there is evidence supporting the benefits of probiotics and prebiotics, limitations exist due to the lack of studies on their use to improve COVID-19 outcomes. The originality of the study is focused on the gut-lung axis and the review of probiotics and prebiotics as potential therapies for COVID-19. By analyzing recent literature, the research contributes to understanding the interactions between diet, gut health, and respiratory infections. It also shows the need for further studies to determine the efficacy of COVID-19, toward new directions for research in the emerging field.

Keywords

Probiotics / prebiotics / mechanisms of action / COVID-19 / immunological system

References

[1] Sampaio F, Sequeira C, Teixeira L. Impact of COVID—19 outbreak on nurses’ mental health: A prospective cohort study. Environ Res. 2021; 194: 110620.

[2] Worobey M. Dissecting the early COVID—19 cases in Wuhan. Science. 2021; 374: 1202—4.

[3] Li Y, Chi W, Su J, Ferrall L, Hung C, Wu T. Coronavirus vaccine development: from SARS and MERS to COVID—19. J Biomed Sci. 2020; 27: 104.

[4] Chong H, Yusoff NAA, Hor Y, Lew L, Jaafar MH, Choi S, et al. Lactobacillus plantarum DR7 improved upper respiratory tract infections via enhancing immune and inflammatory parameters: A randomized, double—blind, placebo—controlled study . J Dairy Sci. 2019; 102: 4783-97.

[5] Cervantes—Barragan L, Chai JN, Tianero MD, Luccia BD, Ahern PP, Merriman J, et al. Lactobacillus reuteri induces gut intraepithelial CD4⁺CD8αα⁺ T cells . Science. 2017; 357: 806—10.

[6] Icaza—Chávez ME. Gut microbiota in health and disease. Rev Gastroenterol Mex. 2013; 78: 240—8.

[7] Tao W, Zhang G, Wang X, Guo M, Zeng W, Xu Z, et al. Analysis of the intestinal microbiota in COVID—19 patients and its correlation with the inflammatory factor IL—18. Med Microecol. 2020; 5: 100023.

[8] Calcuttawala F. Nutrition as a key to boost immunity against COVID—19. Clin Nutr ESPEN. 2022; 49: 17-23.

[9] Araimo F, Imperiale C, Tordiglione P, Ceccarelli G, Borrazzo C, Alessandri F, et al. Ozone as adjuvant support in the treatment of COVID—19: A preliminary report of probiozovid trial. J Med Virol. 2021; 93: 2210-20.

[10] Mirzaei R, Attar A, Papizadeh S, Jeda AS, Hosseini—Fard SR, Jamasbi E, et al. The emerging role of probiotics as a mitigation strategy against coronavirus disease 2019 (COVID—19). Arch Virol. 2021; 166: 1819-40.

[11] Oliveira APd, Lopes ALF, Pacheco G, Nolêto IRdSG, Nicolau LAD, Medeiros JVR. Premises among SARS—CoV—2, dysbiosis and diarrhea: Walking through the ACE2/mTOR/autophagy route. Med Hypotheses. 2020; 144: 110243.

[12] Baş S, Zarbaliyev E. The Role of Dual—Energy Computed Tomography in Locating Gastrointestinal Tract Perforations. Cureus. 2021; 13: e15265.

[13] Wang F, Pan B, Xu S, Xu Z, Zhang T, Zhang Q, et al. A meta—analysis reveals the effectiveness of probiotics and prebiotics against respiratory viral infection. Biosci Rep. 2021; 41: BSR20203638.

[14] Sarkar S. Probiotics as functional foods: documented health benefits. Nutrition & Food Science. 2013; 43: 107-15.

[15] Calder PC. Nutrition and immunity: lessons for COVID—19. Nutr Diabetes. 2021; 11: 19.

[16] Food and Agriculture Organization of the United Nations; World Health Organization. Probiotics in food — Health and nutritional properties and guidelines for evaluation. Food and Agriculture Organization of the United Nations; 2006. pp. 231-44.

[17] Rabaan AA, Al—Ahmed SH, Sah R, Tiwari R, Yatoo MI, Patel SK, et al. SARS—CoV—2/COVID—19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic. Ann Clin Microbiol Antimicrob. 2020; 19: 40.

[18] Favaro L, Barretto Penna AL, Todorov SD. Bacteriocinogenic LAB from cheeses — Application in biopreservation? TIFS. 2015; 41: 37-48.

[19] Wang H, Wang Y, Lu C, Qiu L, Song X, Jia H, et al. The efficacy of probiotics in patients with severe COVID—19. Ann Palliat Med. 2021; 10: 12374-80.

[20] Naskar A, Kim K. Potential Novel Food—Related and Biomedical Applications of Nanomaterials Combined with Bacteriocins. Pharmaceutics. 2021; 13: 86.

[21] Aasen IM, Møretrø T, Katla T, Axelsson L, Storrø I. Influence of complex nutrients, temperature and pH on bacteriocin production by Lactobacillus sakei CCUG 42687 . Appl Microbiol Biotechnol. 2000; 53: 159-66.

[22] Cintas LM, Casaus MP, Herranz C, Nes IF, Hernández PE. Review: Bacteriocins of Lactic Acid Bacteria. Food Sci Technol Int. 2021; 7: 281-305.

[23] Báez—Santos YM, Barraza SJ, Wilson MW, Agius MP, Mielech AM, Davis NM, et al. X—ray structural and biological evaluation of a series of potent and highly selective inhibitors of human coronavirus papain—like proteases. J Med Chem. 2014; 57: 2393-412.

[24] Palacio—Angulo J. Nystatin as a caveolae inhibitor: preventive treatment for COVID—19 infection. IPSA Scientia, Revista Científica Multidisciplinaria. 2020; 5: 36-45.

[25] Sierra L, Montoya O, Ciro HJ. Evaluation of nisin as an inactivating substance of Bacillus licheniformis in liquid coffee extract . MVZ. 2013; 18: 3715-21.

[26] Agudelo N. State of the art of obtaining bacteriocins from lactic acid bacteria and their application in the food industry[dissertation]. Medellín: Universidad Pontificia Bolivariana, School of Engineering; 2013.

[27] Bhattacharya R, Gupta AM, Mitra S, Mandal S, Biswas SR. A natural food preservative peptide nisin can interact with the SARS—CoV—2 spike protein receptor human ACE2. Virology. 2021; 552: 107—11.

[28] Vizcaíno—Carruyo JC, Tangarife—Castaño VJ, Campuzano—Zuluaga G, Toro—Montoya AI. COVID—19 anticuerpos IgM/IgG por ensayo inmunocromatográfico (prueba rápida). Medicina y Laboratorio. 2021; 24: 255-7.

[29] Shyam S, Gómez—Martínez C, Paz—Graniel I, Gaforio JJ, Martínez—González M?, Corella D, et al. Coronavirus disease 2019 is associated with long—term depressive symptoms in Spanish older adults with overweight/obesity and metabolic syndrome. Psychol Med. 2024; 54: 620—30.

[30] Guarner F, Khan AG, Garisch J, Eliakim R, Gangl A, Thomson, A, et al. Probiotics and prebiotics. World Gastroenterology Organization Practical Guide: Probiotics and prebiotics; 2011. pp. 1-29.

[31] Dai T, Song J. Transforming COVID—19 vaccines into vaccination. Health Care Manag Sci. 2021; 24: 455-9.

[32] Álvarez J, Real JMF, Guarner F, Gueimonde M, Rodríguez JM, Pipaon MSd, et al. Gut microbes and health. Gastroenterol Hepatol. 2021; 44: 519-35.

[33] Davani—Davari D, Negahdaripour M, Karimzadeh I, Seifan M, Mohkam M, Masoumi SJ, et al. Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical Applications. Foods. 2019; 8: 92.

[34] Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID—19) outbreak. J Autoimmun. 2020; 109: 102433.

[35] Chowdhury MA, Hossain N, Kashem MA, Shahid MA, Alam A. Immune response in COVID—19: A review. J Infect Public Health. 2020; 13: 1619-29.

[36] Aljadani H. Impact of Different Dietary Patterns and Micronutrients on the Immune System and COVID—19 Infection. Curr Res Nutr Food Sci Jour. 2021; 9; 127-38.

[37] Ye Q, Wang B, Mao J. The pathogenesis and treatment of the `Cytokine Storm' in COVID—19. J Infect. 2020; 80: 607—13.

[38] Ebrahimpour—Koujan S, Sohrabpour AA, Safari S, Baziar N, Hadavi S, Payahoo L, et al. A comprehensive nutritional support perspective in patients with COVID—19: a review. Nutrition & Food Science. 2023; 53: 334-57.

[39] d'Ettorre G, Ceccarelli G, Marazzato M, Campagna G, Pinacchio C, Alessandri F, et al. Challenges in the Management of SARS—CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID—19. Front Med (Lausanne). 2020; 7: 389.

[40] Ng QX, Lim YL, Yaow CYL, Ng WK, Thumboo J, Liew TM. Effect of Probiotic Supplementation on Gut Microbiota in Patients with Major Depressive Disorders: A Systematic Review. Nutrients. 2023; 15: 1351.

[41] Tao YW, Gu YL, Mao XQ, Zhang L, Pei YF. Effects of probiotics on type II diabetes mellitus: a meta—analysis. J Transl Med. 2020; 18: 30.

[42] Markowiak—Kopeć P, Śliżewska K. The Effect of Probiotics on the Production of Short—Chain Fatty Acids by Human Intestinal Microbiome. Nutrients. 2020; 12: 1107.

[43] Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014; 11: 506—14.

[44] Amadi B, Mwiya M, Musuku J, Watuka A, Sianongo S, Ayoub H, et al. Effect of probiotics on the incidence of diarrhea in malnourished children: a randomized, double—blind, placebo—controlled trial. Am J Clin Nutr. 2020; 111: 1324—33.

[45] Sindhu KNC, Bindels LB, Segers ME, Kessel JB, Wilms E, Snel J, et al. Probiotic administration in early life affects the gut microbiota and improves growth in infant mice. Sci Transl Med. 2020; 12: eaay7896.

[46] Xiao J, Chen H, Kang D, Shao Y, Zhao Y, Zhu J, et al. Probiotics in the treatment of depression: a systematic review and meta—analysis of randomized controlled trials. Nutrients. 2021; 13: 1227.

[47] Tomas J, Saffarian A, Chakaroun R, Mayneris—Perxachs J, Lan A, Levenez F, et al. High—fat diet modifies the PPAR—γ pathway leading to disruption of microbial and physiological ecosystem in murine small intestine. PNAS. 2020; 117: 24220—30.

[48] Ferro M, Charneca S, Dourado E, Guerreiro CS, Fonseca JE. Probiotic Supplementation for Rheumatoid Arthritis: A Promising Adjuvant Therapy in the Gut Microbiome Era. Front Pharmacol. 2021; 12: 711788.